Therefore, decrease in the level of the pro-inflammatory NF-κB in Na-Bu and BAY 61-3606-treated VS tumour samples can be partly explained by the concomitant increase in the level of TGF-β1 (Figures 4a–c and 5a–c). The gene discussed is NFKB1; the disease is neoplasm.